Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effects of Imatinib Mesylate in Mouse Models of Multiple Sclerosis and In vitro Determinants.
Life-threatening asthma attack during prolonged fingolimod treatment: case report.
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response.
The impact of walking speed on the effects of functional electrical stimulation for foot drop in people with multiple sclerosis.
Pediatric Multiple Sclerosis.
Resveratrol effects on astrocyte function: Relevance to neurodegenerative diseases.
25-Hydroxycholecalciferol status in plasma is linearly correlated to daily summer pasture time in cattle at 56°N.
Glutamate inhibition in MS: the neuroprotective properties of riluzole.
The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury.
Home-based exercise program and fall-risk reduction in older adults with multiple sclerosis: phase 1 randomized controlled trial.
Natalizumab in spinal multiple sclerosis in a daily clinical setting.
Neurocardiogenic Pulmonary Oedema: Initial Presentation of Multiple Sclerosis.
Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI.
Managing MS: Trends, Issues, and Perspectives.
The nervous system's potential role in multiple sclerosis associated bone loss.
Lipid microarrays identify key mediators of autoimmune brain inflammation.
Limb ataxia originating from peri-central sulcus demyelinating lesion in multiple sclerosis.
[Application of laser therapy in the physiotherapy of patients with multiple sclerosis].
A case of septal panniculitis secondary to interferon treatment.
Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review.
[Biomarkers in multiple sclerosis].
Hematologic modifications in natalizumab-treated multiple sclerosis patients: An 18-month longitudinal study.
Acute transverse myelitis: an unusual complication of typhoid fever.
CCSVI is associated with multiple sclerosis.
Pages
« first
‹ previous
…
229
230
231
232
233
234
235
236
237
…
next ›
last »